Over recent weeks, WellSky International Ltd (WellSky) has been working behind the scenes with key representative of its large Pharmacy system customer base on the UK’s national COVID vaccination programme.
The specific project purpose was to enable the hospitals identified as COVID vaccine hubs to monitor the receipt and issue of the vaccine, and to enable standardised reporting of the usage of the vaccine. The project goal was to assist in overcoming the logistical challenges of managing a national vaccination programme at pace.
An initial cohort of nearly 50 NHS customers were provided with standarised guidance on how the vaccine should be configured within WellSky Pharmacy systems to allow the reporting to be achieved at a national level. Their systems were updated and tested within a two-week period.
WellSky re-purposed existing configurations of systems to capture and report on the required data elements to a specification provided by NHSx. With vaccinations anticipated to commence from December 7, the project timeframes have been extremely challenging.
The UK, as reported, has been the first nation in the world to approve the Pfizer/BioNTech vaccine. WellSky is delighted to have played a part in the management and distribution process for this life saving vaccine in hospitals in England and Scotland.
We’d like to congratulate our customers on their rapid response and work over the past few weeks to ready their WellSky Pharmacy system for the initial Pfizer/BioNTech vaccine program and future vaccines as they are brought to market. Their dedication to this national effort is a testament to the NHS and country as a whole.